Destiny Pharma plc
DEST.L · LSE
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | £63,470 | £37,558 | £62,861 | £30,984 |
| - Cash | £6,383 | £4,903 | £4,646 | £9,744 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | £57,087 | £32,654 | £58,216 | £21,240 |
| Revenue | £832 | £154 | £135 | £12 |
| % Growth | 438.2% | 14.4% | 984.6% | – |
| Gross Profit | £825 | £142 | £123 | -£4 |
| % Margin | 99.3% | 92% | 90.7% | -35.6% |
| EBITDA | -£6,564 | -£7,764 | -£6,274 | -£6,536 |
| % Margin | -789.3% | -5,025.3% | -4,646.8% | -52,495% |
| Net Income | -£5,657 | -£6,504 | -£5,339 | -£5,411 |
| % Margin | -680.3% | -4,209.5% | -3,954.4% | -43,462.5% |
| EPS Diluted | -0.062 | -0.093 | -0.089 | -0.12 |
| % Growth | 32.6% | -3.8% | 25.7% | – |
| Operating Cash Flow | -£5,185 | -£5,827 | -£5,075 | -£5,421 |
| Capital Expenditures | -£81 | -£1 | -£30 | -£2,264 |
| Free Cash Flow | -£5,266 | -£5,829 | -£5,105 | -£7,684 |